Check-Cap (NASDAQ:CHEK) Stock Price Passes Below 50-Day Moving Average of $0.34

Check-Cap Ltd. (NASDAQ:CHEKGet Rating) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.34 and traded as low as $0.32. Check-Cap shares last traded at $0.32, with a volume of 190,801 shares traded.

Check-Cap Price Performance

The stock has a market cap of $31.06 million, a PE ratio of -1.61 and a beta of 0.31. The firm’s 50 day moving average price is $0.34 and its two-hundred day moving average price is $0.36.

Hedge Funds Weigh In On Check-Cap

An institutional investor recently raised its position in Check-Cap stock. Virtu Financial LLC boosted its position in shares of Check-Cap Ltd. (NASDAQ:CHEKGet Rating) by 363.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 224,696 shares of the medical research company’s stock after acquiring an additional 176,207 shares during the period. Virtu Financial LLC owned 0.23% of Check-Cap worth $69,000 as of its most recent SEC filing. Institutional investors own 1.33% of the company’s stock.

Check-Cap Company Profile

(Get Rating)

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.

Further Reading

Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with's FREE daily email newsletter.